Adenosine Administration Guidelines
Introduction to Adenosine Administration
- The American Heart Association recommends administering adenosine as a rapid IV push through a large vein, followed by a 20 mL saline flush, and as close to the heart as possible 1
- Adenosine administration should be done in a monitored environment, such as a critical care unit or emergency department, with a defibrillator available, especially when WPW is a consideration 1
- The British Medical Association notes that adenosine may cause bronchospasm in patients with asthma 2
Patient Selection and Monitoring
- Patients with pre-excited atrial fibrillation or flutter with WPW syndrome should avoid IV amiodarone, adenosine, digoxin, or nondihydropyridine calcium channel antagonists, as recommended by the American College of Cardiology 3
- Continuous monitoring of heart rate and blood pressure is essential during adenosine administration, and for at least 2-3 minutes after administration, due to the potential for profound bradycardia and AV block 2
- The European Society of Cardiology suggests that patients with second or third-degree AV block without a pacemaker, or sinus node dysfunction without a pacemaker, should not receive adenosine 2
Dosing and Administration
- The initial adenosine dose may need to be reduced when administering to patients on amiodarone, and dipyridamole may enhance the effect of adenosine, requiring further dose reduction, as noted by the American Heart Association 1
- Theophylline and caffeine can reduce adenosine's effects, according to the British Medical Association 1
- Heart transplant recipients require lower adenosine doses, as recommended by the International Society for Heart and Lung Transplantation 1
Potential Adverse Effects
- Common adverse effects of adenosine include flushing, chest discomfort, and dyspnea, which typically last less than 60 seconds due to adenosine's short half-life, as reported by the British Journal of Sports Medicine 2
- Transient complete heart block is an expected pharmacologic effect of adenosine, and temporary pacing may be needed if profound bradycardia occurs, as noted by the American College of Cardiology 1
- Adenosine can cause temporary AV nodal conduction block and interrupts reentry circuits involving the AV node, and has a short half-life, making it relatively safe even with potential interactions 4
- When used with amiodarone, caution is advised due to the potential for increased bradycardia risk, and careful monitoring is necessary, especially in patients with pre-existing conduction disorders, as advised by the European Society of Cardiology 1
Contraindications and Precautions
- Amiodarone is contraindicated in patients with:
- Patients with ventricular dysfunction, congenital heart disease, cyanotic heart disease, or prior Fontan procedure are at higher risk of adverse events, including thyroid disorders, when taking amiodarone, as noted by the American Heart Association 8
- Female patients with low body mass index are at increased risk of thyrotoxicosis when taking amiodarone, according to the American Heart Association 8
Monitoring and Management of Adverse Effects
- Close monitoring of heart rate is necessary, especially during the first week of treatment, and a directed clinical evaluation should be performed to detect anticipated adverse effects, including bradycardia, as recommended by the American Family Physician 7
- When bradycardia occurs, the infusion should be suspended or the infusion rate reduced for intravenous administration, and the dose should be considered for reduction for oral administration, as suggested by the American Family Physician 7
- In severe cases, a temporary or permanent pacemaker may be required, as stated by the American Family Physician and Circulation guideline societies 7, 8
- Holter monitoring in high-risk patients can help detect and manage bradycardia, as recommended by the American Family Physician 7
Special Considerations
- Amiodarone should generally be used for patients with atrial fibrillation when other agents have failed or are contraindicated due to its toxicity profile, as recommended by the European Heart Society 5
- Amiodarone can potentiate the risk of bradycardia when used with digoxin, which can double digoxin levels, as warned by the American Family Physician and Circulation guideline societies 7, 8
- In patients with severe heart failure, amiodarone may be the only antiarrhythmic option, despite the risks, as suggested by the European Heart Society 5